A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
A phase 2, randomized, vehicle-controlled, double-blind study to assess the efficacy, safety
and pharmacodynamics (PD) of topically applied CLS003 in otherwise healthy patients with
cutaneous warts.